Somatic mutations of the EGF receptor and their signal transducers affect the efficacy of EGF receptor-specific tyrosine kinase inhibitors

Ítems similars

• Multiple myeloma is affected by multiple and heterogeneous somatic mutations in adhesion- and receptor tyrosine kinase signaling molecules
  per: Leich, E, et al.
  Publicat: (2013)
• Activation of AMP-activated protein kinase by human EGF receptor 2/EGF receptor tyrosine kinase inhibitor protects cardiac cells
  per: Spector, Neil L., et al.
  Publicat: (2007)
• Targeting the EGF receptor in ovarian cancer with the tyrosine kinase inhibitor ZD 1839 (‘Iressa’)
  per: Sewell, J M, et al.
  Publicat: (2002)
• Effect of EGF-receptor tyrosine kinase inhibitor on Rab5 function during endocytosis
  per: Jozic, Ivan, et al.
  Publicat: (2012)
• Mutations in the cytoplasmic domain of EGF receptor affect EGF binding and receptor internalization.
  per: Prywes, R, et al.
  Publicat: (1986)